Company Statement: Takeda to acquire Multilab, enhancing its business infrastructure in Brazil
MLex Summary: Tokyo Stock Exchange-listed Japanese Takeda Pharmaceutical has agreed to acquire Brazilian drugmaker Multilab Indústria e Comércio de Produtos Farmacêuticos for 500 million reais. Takeda expects that the transaction will be finalized by...To view the full article, register now.
Already a subscriber? Click here to view full article